Ralph J. Gabric
Shareholder
概观

“My client’s problems are my problems.  I am personally invested, and always thinking about ways for achieving victory in the most cost-effective manner while also keeping an eye out for settlement opportunities.”

Ralph has served on the firm’s Board of Directors and is the former chair of the firm’s litigation practice group. Ralph is a trial lawyer with over 30 years of experience handling patent matters, serving as lead counsel in numerous cases. He has successfully represented clients in both jury and bench trials, and appeals to the U.S. Court of Appeals for the Federal Circuit, as well as in post-grant review proceedings before the Patent Trial and Appeal Board. Ralph served as co-lead defense counsel in one of the most significant patent defense jury verdicts ever, and served as lead counsel for the petitioner invalidating all challenged claims (affirmed on appeal) in what is the largest post-grant review proceeding to date, involving nearly 20 depositions and declarations. Intellectual Asset Management (IAM) magazine writes that Ralph is “incredibly client-oriented” and “an awesome orator who instantly connects with juries.”

Ralph has extensive experience handling matters involving a variety of technologies, including software, medical devices, communications networks, cellular telephony, automotive, infrared cameras, and various internet-based technologies. Ralph also has substantial experience in representing generic pharmaceutical companies in Hatch-Waxman pharmaceutical litigation, serving as lead counsel in cases involving numerous drug products.

Ralph has been consistently named by publications that recognize attorney achievement, having been recognized by The Best Lawyers in America, the IAM Patent 1000The World’s Leading Patent Professionals, and Chambers U.S.A. for multiple years. Ralph has also repeatedly been recognized as an Illinois Super Lawyer in patent litigation.

教育
  • J.D.,
    德保罗大学法学院, 1988
  • B.S., Chemistry,
    Boston College, 1985
执业准许
  • Illinois
  • Supreme Court of the United States
  • U.S. Court of Appeals, 6th Circuit
  • U.S. Court of Appeals, 8th Circuit
  • U.S. Court of Appeals, 9th Circuit
  • U.S. Court of Appeals, Fed. Cir.
  • U.S. Dist. Court, Dist. of Colorado
  • U.S. Dist. Court, Dist. of Delaware
  • U.S. Dist. Court, Dist. of Maryland
  • U.S. Dist. Court, Dist. of New Jersey
  • U.S. Dist. Court, E.D. Michigan
  • U.S. Dist. Court, E.D. Texas
  • U.S. Dist. Court, N.D. California
  • U.S. Dist. Court, N.D. Illinois, Trial Bar
  • U.S. Dist. Court, S.D. Illinois
  • U.S. Dist. Court, S.D. Indiana
  • U.S. Dist. Court, S.D. New York
  • U.S. Dist. Court, W.D. Michigan
  • U.S. Patent & Trademark Office
技术背景
  • Biopharma
  • Chemistry
经验 | Legal

Brinks Gilson & Lione, Chicago, IL
Shareholder, 1996 – Present
Associate, 1988 – 1995

经验 | Clerkship & Internships

DePaul University College of Law, Chicago, IL
Member of the DePaul Law Review, 1986 – 1988

演讲
  • "PTAB Live: Thoughts on Practice, Procedure, IPRs and More in the World of Pharmaceutical Patent Validity Challenges," ACI Paragraph IV Disputes, New York, NY, April 2017
  • "Generic Drug Litigation in the U.S.," 7th Annual Generic International Summit, Shanghai, China, April 2017
  • "Parallel Proceedings Moot Court: District Court and PTAB Mock Pharmaceutical Patent Invalidity Hearing,” Brinks Sponsoring ACI Paragraph IV Disputes, New York, NY, April 2016
  • "The PTAB Live," ACI's Paragraph IV Disputes Conference, New York, NY, April 2016
  • "A View From the Bench: The Federal Judges Speak," ACI's Paragraph IV Disputes Conference, New York, NY, April 2015
  • "Working with Local Counsel and Within Local Rules: Magistrate and Local Counsel Roundtable," ACI's Paragraph IV Disputes Master Symposium, New York, NY, April 2014
代理案件
  • Sysmex America, Inc. and Sysmex Corporation v. Beckman Coulter, Inc., (N.D. Ill., 2018 – Present) – Lead counsel in Declaratory Judgment action on behalf of Sysmex seeking declaration of non-infringement and invalidity of patent involving laboratory instrument software that is ongoing
  • Adverio Pharma Gmbh, Bayer AG, and Bayer Healthcare Pharmaceuticals Inc. v. Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., and INC Research, LLC, C.A., (D. Del., 2018 – Present) – Lead counsel defending Alembic in patent infringement case relating to the drug Adempas®, that is ongoing
  • Beckman Coulter, Inc. v. Sysmex America, Inc. and Sysmex Corporation, (S.D. Fla., 2017 – Present) (transferred to N.D. Ill) – Lead counsel for Sysmex defendants in patent infringement case regarding laboratory instrument software that is ongoing
  • Duke University, Allergan, Inc. and Allergan Sales, LLC v. Alembic Pharmaceuticals, Ltd., Alembic Global Holding SA and Alembic Pharmaceuticals, Inc., (D. N.J., 2017 – Present) – Lead counsel defending Alembic in patent infringement case relating to biomatoprost ophthalmic solution, Latisse®, that is ongoing
  • Fontem Ventures B.V. and Fontem Holdings 1 B.V. v. R.J. Reynolds Vapor Co., (C.D. Cal., 2016) – Lead counsel defending R.J Reynolds Vapor Co. in patent infringement case that was transferred from M.D.N.C., relating to a tobacco product that settled favorably
  • Sanofi-Aventis U.S. LLC, Aventisub LLC, Sanofi, and Genzyme Corporation, v. Alembic Pharmaceuticals Ltd., Alembic Limited, Alembic Global Holding SA, and Alembic Pharmaceuticals, Inc., (D. Del., 2016 – Present) – Lead counsel for defendant in patent infringement case regarding prescription drug Aubagio® that is ongoing
  • In the Matter of Certain Portable Electronic Devices and Components Thereof,  (ITC Inv. No. 337 – TA – 994, 2016) – Counsel for respondents ZTE Corporation and ZTE (USA) Inc. in patent infringement case involving cell phones where patent held invalid for lack of utility
  • Dow Pharmaceutical Sciences, Inc. and Valeant Pharmaceuticals North America LLC v. Actavis Laboratories UT, Inc., Actavis Inc., and Allergan PLC formerly known as Actavis PLC, (D. N.J., 2016) – Lead counsel for defendants Actavis in patent infringement case relating to Onexton®, a benzoyl peroxide and clindamycin phosphate topical gel, that was favorably settled
  • Panasonic Corporation v. MobileDemand LLC, (D. N.J., 2016) – Lead counsel for Panasonic in patent infringement case regarding tablet computers that was favorably settled
  • Creative Technology Ltd v. ZTE Corporation and ZTE (USA) Inc., (E.D. Tex., 2016 and ITC) – Lead counsel for defendants in patent infringement case involving cell phones where patent was held invalid by ITC
  • Horizon Pharma Ireland Ltd. v. Actavis Laboratories UT, Inc., (D. N.J., 2014) – Lead counsel in patent infringement case relating to Pennsaid®, a diclofenac sodium topical solution, that found that many claims were held invalid or not infringed by the district court
  • Noven Therapeutics, LLC v. Actavis Laboratories FL, Inc., Actavis Pharma, Inc., ANDRX Corp., and Actavis, Inc., (D. N.J., 2014) – Lead counsel for defendants in patent infringement case relating to the medication Brisdelle®, a paroxetine mesylate, that was favorably settled
  • AstraZeneca AB v. Watson Laboratories, Inc., Actavis, Inc., and Actavis LLC, (D. Del., 2014) – Lead counsel for defendants in patent infringement case relating to Onglyza® (saxagliptin) and Kombiglyze® (saxagliptin and metformin HCl) that was favorably settled
  • Kia Motors America, Inc. and Kia Motors Corporation v. Peter F. Wingard, (N.D. Ill., 2014) – Lead counsel for Kia Motors in declaratory judgment action for non-infringement of patent involving automotive technology that was favorably settled
  • Noven Pharmaceuticals, Inc. v. Watson Laboratories, Inc. et al., (D. N.J., 2014) – Lead counsel for generic client in Hatch-Waxman patent litigation in a first to file (FTF) opportunity related to a methylphenidate transdermal patch sold by Noven as Daytrana® that was favorably settled
Post-Grant Patent Office Proceedings
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2018 – 00626 – 00634) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPRs related to electronic cigarette technology for U.S. Patents 8,375,957; 8,393,331; 8,863,752; 9,364,027; 9,339,062; 9,326,550; 9,326,551; and 9,456,632 that is ongoing
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2017 – 01641 – 01642) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPRs related to electronic cigarette technology for U.S. Patent 9,370,205
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2017 – 01318 – 01319) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPRs related to electronic cigarette technology for U.S. Patent 9,326,549
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2017 – 01180) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPR related to electronic cigarette technology for U.S. Patent 8,893,726
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2017 – 01117 – 01120) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPRs related to electronic cigarette technology for U.S. Patents 8,893,726; 8,490,628; and 8,899,239
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2016 – 01859) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPR related to electronic cigarette technology for U.S. Patent 9,326,549
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2016 – 01691 – 01692) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPRs related to electronic cigarette technology for U.S. Patent 9,326,548
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2016 – 01532) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPR related to electronic cigarette technology for U.S. Patent 8,365,742
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2016 – 01527) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPR related to electronic cigarette technology for U.S. Patent 8,490,628
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2016 – 01272) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPR related to electronic cigarette technology for U.S. Patent 8,899,239
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2016 – 01270) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPR related to electronic cigarette technology for U.S. Patent 8,893,726
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., (IPR2016 – 01268) – Lead counsel for petitioner R.J. Reynolds Vapor Company in IPR related to electronic cigarette technology for U.S. Patent 8,365,742
  • Sandoz Inc. v. Eli Lilly & Co., (IPR2016 – 00318) – Lead counsel for petitioner Sandoz Inc. in IPR related to pemetrexed (Alimta®)for U.S. Patent 7,772,209
  • Continental Automotive Gmbh, Kia Motors Corporation, and Kia Motors America, Inc. v. Netlatch, LLC, (IPR2015 – 00481) – Lead counsel for petitioner Kia Motors in IPR related to automotive technology  for U.S. Patent 5,530,431 B2
  • FLIR Systems, Inc. v. Leak Surveys, Inc., (IPR2015 – 00065) – Lead counsel for petitioner FLIR Systems, Inc. in IPR related to infrared cameras for U.S. Patent 8,426,813
  • FLIR Systems, Inc. v. Leak Surveys, Inc., (IPR2014 – 00608 – 00609) – Lead counsel for petitioner FLIR Systems, Inc. in IPRs related to infrared cameras for U.S. Patents 8,426,813 and 8,193,496
  • FLIR Systems, Inc. v. Leak Surveys, Inc., (IPR2014 – 00434) – Lead counsel for petitioner FLIR Systems, Inc. in IPR related to infrared cameras for U.S. Patent 8,193,496
  • FLIR Systems, Inc. v. Leak Surveys, Inc., (IPR2014 – 00411) – Lead counsel for petitioner FLIR Systems, Inc. in IPR related to infrared cameras for U.S. Patent 8,426,813
  • Honda Tsushin Kogyo Co., Ltd. v. Advanced Connection Technology, Inc., (IPR2014 – 00307, USPTO) – Lead counsel for petitioner Honda Tsushin Kogyo Co. Ltd. in IPR related to infant incubators for U.S. Patent 7,128,617
  • Atom Medical International, Inc. v. Draeger Medical System, Inc., (IPR2014 – 00232, USPTO) – Lead counsel for petitioner Atom Medical International, Inc. in IPR related to infant incubators for U.S. Patent No. 6,345,402
  • Atom Medical International, Inc. v. Draeger Medical System, Inc., (IPR2014 – 00194, USPTO) – Lead counsel for petitioner Atom Medical International, Inc. in IPR related to infant incubators for U.S. Patent No. 7,335,157
  • Atom Medical International, Inc. v. Draeger Medical System, Inc., (IPR2014 – 00095, USPTO) – Lead counsel for petitioner Atom Medical International, Inc. in IPR related to infant incubators for U.S. Patent No. 6,483,080
Pro Bono (Trial Bar Appointments)
  • Adams v. Dart, (N.D. Ill., 2019) – Counsel for petitioner in constitutional rights case that is ongoing.
新闻报道和活动
October 24, 2018

CHICAGO—Brinks shareholder Gary M. Ropski has been named the #1 Leading Intellectual Property Lawyer in Illinois and  Laura Beth Miller has been recognized among the Top...

August 15, 2018

CHICAGO—Fourteen attorneys at Brinks Gilson & Lione, one of the largest intellectual property law firms in the United States, have been selected by their peers for inclusion in The Best Lawyers in America 2019...

June 08, 2018

CHICAGO—Intellectual property law firm Brinks Gilson & Lione is an “international player” and a “top IP boutique” having just “opened its office in Shenzhen, China,” according to Intellectual Asset Management (IAM) magazine’s annual guide to leading private practice patent professionals and firms in the world’s key jurisdictions, the IAM Patent 1000 2018–The World’s Leading Patent Professionals.

August 15, 2017

CHICAGO—Fifteen attorneys at Brinks Gilson & Lione, one of the largest intellectual property law firms in the United States, have been selected by their peers for inclusion in The Best Lawyers in America 2018...

July 13, 2017

CHICAGO—Intellectual property law firm Brinks Gilson & Lione is a “top U.S. boutique” and a “Chicago IP stalwart” with “deep reservoirs of prosecution and litigation experience,” according to Intellectual Asset Management (IAM) ...

June 06, 2017

CHICAGO—Best Lawyers, a widely-respected peer review publication for the legal profession, recently recognized eleven attorneys at intellectual property law firm Brinks Gilson & Lione in its 2017 edition of Illinois’ Best Lawyers...

May 31, 2017

CHICAGO—Ralph J. Gabric, a shareholder and patent litigator at intellectual property law firm Brinks Gilson & Lione, will be a panelist for the session “Claim Construction,” at the Federal Circuit Bar Association’s 2017 Bench & Bar Conference in Coeur d’Alene, Idaho on June 22, 2017.

April 25, 2017
On April 25, 2017, at the ACI Paragraph IV Conference, Ralph Gabric will moderate the panel, PTAB Live: Thoughts on Practice, Procedure, IPRs and More in the World of Pharmaceutical Patent Validity Challenges, which will discuss: The ...
April 21, 2017

CHICAGO—Ralph J. Gabric and Laura A. Lydigsen, shareholders and patent litigators at intellectual property law firm Brinks Gilson & Lione, will be featured presenters at the 11th Annual ACI Paragraph IV Disputes Conference on April 25, 2017, at the Conrad New York...

March 27, 2017
CHICAGO—Six attorneys and shareholders at intellectual property law firm Brinks Gilson & Lione have been selected for inclusion in Euromoney PLC’s 2017 Expert Guide to the World’s Leading Patent Law Practitioners: William H. ...
February 09, 2017

CHICAGO—Twenty attorneys at intellectual property law firm Brinks Gilson & Lione have been named to the 2017 ...

August 15, 2016

CHICAGO—Fifteen attorneys at Brinks Gilson & Lione, one of the largest intellectual property law firms in the United  ...

April 25, 2016
Mark Remus will participate in, "Parallel Proceedings Moot Court: District Court and PTAB Mock Pharmaceutical Patent Invalidity Hearing" This interactive session will illustrate the ins and outs of this balancing act through a mock ...
January 12, 2016

CHICAGO—Twenty-two attorneys at intellectual property law firm Brinks Gilson & Lione have been named to the 2016 ...

September 01, 2015
CHICAGO—Intellectual property law firm Brinks Gilson & Lione announced today that Mark H. Remus has rejoined the firm as a partner in its Chicago office. Remus is a seasoned trial lawyer who has served as lead counsel on numerous patent ...
August 17, 2015
CHICAGO—Thirteen attorneys at Brinks Gilson & Lione, one of the largest intellectual property law firms in the United States, were recently listed in The Best Lawyers in America 2016.  Eleven of the honored attorneys are based in ...
January 20, 2015
CHICAGO—Twenty-four attorneys at Brinks Gilson & Lione, one of the nation's largest intellectual property law firms, are named to the 2015 Illinois Super Lawyers list by Super Lawyers, a rating service that lists lawyers from more than ...
October 23, 2014
CHICAGO—Gary M. Ropski, a shareholder at intellectual property law firm Brinks Gilson & Lione and the firm's past president, has been named the #1 Leading Intellectual Property Lawyer in Illinois by Leading Lawyers, and fifty-nine ...
August 19, 2014
CHICAGO—Sixteen shareholders at Brinks Gilson & Lione, one of the largest intellectual property law firms in the United States, have been selected by their peers for inclusion in The Best Lawyers in America© 2015. Thirteen of the ...
June 16, 2014
CHICAGO— Each year, Intellectual Asset Management magazine's IAM Patent 1000—The World’s Leading Patent Practitioners spotlights best-in-class patent prosecution, licensing and litigation practitioners and firms, and this year ...
January 14, 2014
CHICAGO -- Brinks Gilson & Lione, one of the nation’s largest intellectual property law firms, has announced the 2014 chairpersons of its legal and industry practice groups and geographic task forces. The firm added a new practice group ...
荣誉
  • The Best Lawyers in America, Intellectual Property, 2009 – 2019
  • Leading Patent Practitioner, Intellectual Asset Management magazine's "IAM Patent 1000 – The World’s Leading Patent Practitioners," 2013 – 2018
  • Illinois Super Lawyers, Intellectual Property Litigation, 2006 – 2017
  • Named, Euromoney Expert Guide to the World's Leading Patent Law Practitioners, 2017
  • Leading Intellectual Property Lawyer, Leading Lawyers Network, Law Bulletin Publishing Company, 2004 – 2016
联盟协会
  • Intellectual Properties Owners (IPO)